A recent town hall event detailed the School of Medicine’s endowment income, gifts and other income, and included a financial update and forecast.

The report finds a rapid increase in the volume and utility of health-related data, creating an opportunity to democratize health care.

Adding buildings and moving research and administrative operations to off-campus locations will allow the School of Medicine to rebuild on campus and meet its growing need for space, school leaders say.

In the new role of associate dean for market development, Ronald Dalman will partner with Stanford Health Care business development leadership and others to fulfill regional goals of the integrated strategic plan.

Paul King will become the president and CEO of Stanford Children’s Health in early 2019.

Three individuals will be awarded the Dean’s Medal for their contributions to the mission of Stanford Medicine.

A cancer biologist, Artandi studies the role of telomerase in stem cells and cancer. He replaces outgoing director Beverly Mitchell.

The university is opposing the ballot initiative because of the effect it would have on Stanford Health Care.

An initiative on the November ballot in the City of Palo Alto would significantly affect the delivery of health care within the city, including at Stanford Health Care. Three university leaders discuss the issues behind the initiative and the impacts they foresee.

At this year’s State of Stanford Medicine event, the dean, hospital CEOs and a special guest shared their reflections on the strengths and challenges of the medical center today.